Tuesday, May 21, 2024



‘Misleading and fallacious’: Govt refutes reports claiming that Covaxin approval was rushed due to political pressure, Bharat Biotech also denies

Govt of India and Bharat Biotech deny claims that approval for Covaxin was rushed and procedures were skipped

Germany recognises Bharat Biotech’s Covid-19 vaccine Covaxin, removes testing requirements for travel from next month

German government had decided to recognise WHO-listed Covaxin for travels to Germany starting June 1.

As Covid-19 vaccine precaution doses become available at private hospitals, Covishield and Covaxin prices cut to Rs 225

Serum Institute of India and Bharat Biotech reduce the price of Covishield and Covaxin vaccines to ₹225 per dose

Court orders The Wire to take down 14 articles against Bharat Biotech and Covaxin, not to publish any more defamatory reports

A court in Telangana has ordered The Wire to take down 14 articles it had published against Bharat Biotech

Studies suggest COVAXIN booster dose highly effective against Omicron and Delta variant: Details

Booster dose of COVAXIN is safe and may be necessary to ensure persistent immunity to prevent breakthrough infections.

Pfizer CEO Bourla says COVID vaccines offer limited protection ‘if any’, adds third dose gives less protection against infection

Speaking exclusively to CNBC, Pfizer CEO Bourla stated that the vaccine against Omicron will be available in March.

India’s COVID-19 vaccine coverage surpasses the 150-crore mark; 25% of the eligible teens register in the first week: Details

The landmark feat of jabbing 150 crore doses was achieved on January 7, a year after the commencement of vaccination drive

‘Please be responsible’: Bharat Biotech ‘fact-checks’ TOI, Wire and others who have spread lies against Covaxin

Bharat Biotech has shared a list of media outlets who have spread false information against Covaxin in the last few days.

Before NDTV journalist Vishnu Som rushes to cast aspersions on the shelf life extension to Covaxin, he should read his own channel’s report: Details

Vishnu Som had recently taken to Twitter to question the extension of shelf life granted to Bharat Biotech's Covaxin

Latest News

Recently Popular